317 filings
Page 6 of 16
8-K
77w9gnd6
24 Oct 17
Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices
12:00am
8-K
ph4voojsw279gpf
23 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
b626t
19 Oct 17
Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices
12:00am
8-K
kz2cd
14 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
21zl173o3 qat
11 Sep 17
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent Developments
12:00am
8-K
i4uo7jsyaq3fs7kky
11 Sep 17
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid Bioservices
12:00am
8-K
u1w p2j5071jmqkue
5 Sep 17
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
8-K
sbnczfovyh4te9cr11
11 Aug 17
Peregrine Announces Measures to Reduce Costs, Facilitate Profitability and Strengthen its Operations
12:00am
8-K
8yxaoly7ei5o92zf
25 Jul 17
Other Events
12:00am
8-K
nka amobcr
14 Jul 17
Results of Operations and Financial Condition
12:00am
8-K
s79vgvmxy7 zo5
7 Jul 17
Peregrine Pharmaceuticals Announces Reverse Stock Split
12:00am
8-K
agvalptsyvqp32kxy
7 Jun 17
Other Events
12:00am
8-K
bsc9e0dmf
6 Jun 17
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
8-K
uat3tw3m74i
12 Apr 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
u88dyxc
13 Mar 17
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2017 and Recent Developments
12:00am
8-K
gn35zc5t
9 Mar 17
Other Events
12:00am
8-K
e0vqvo54 q2
12 Dec 16
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2017 and Recent Developments
12:00am
8-K
dka4djtywszhv zn
6 Dec 16
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
12:00am
8-K
k4dmc
13 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
l3ttk
12 Oct 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am